140 related articles for article (PubMed ID: 18953683)
1. Valproic acid attenuates inflammation in experimental autoimmune neuritis.
Zhang Z; Zhang ZY; Fauser U; Schluesener HJ
Cell Mol Life Sci; 2008 Dec; 65(24):4055-65. PubMed ID: 18953683
[TBL] [Abstract][Full Text] [Related]
2. MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis.
Zhang ZY; Zhang Z; Schluesener HJ
Neuroscience; 2010 Aug; 169(1):370-7. PubMed ID: 20451583
[TBL] [Abstract][Full Text] [Related]
3. Doxycycline attenuates peripheral inflammation in rat experimental autoimmune neuritis.
Yi C; Zhang Z; Wang W; Zug C; Schluesener HJ; Zhang Z
Neurochem Res; 2011 Nov; 36(11):1984-90. PubMed ID: 21656035
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats.
Zhang Z; Zhang ZY; Wu Y; Schluesener HJ
Neuroscience; 2012 Sep; 221():140-50. PubMed ID: 22800566
[TBL] [Abstract][Full Text] [Related]
5. Resistance and susceptibility to experimental autoimmune neuritis in Sprague-Dawley and Lewis rats correlate with different levels of autoreactive T and B cell responses to myelin antigens.
Zhu J; Zou LP; Bakhiet M; Mix E
J Neurosci Res; 1998 Nov; 54(3):373-81. PubMed ID: 9819142
[TBL] [Abstract][Full Text] [Related]
6. Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects.
Zhang Z; Zhang ZY; Schluesener HJ
J Immunol; 2009 Sep; 183(5):3081-91. PubMed ID: 19675162
[TBL] [Abstract][Full Text] [Related]
7. Curcumin ameliorates rat experimental autoimmune neuritis.
Han F; Luo B; Shi R; Han C; Zhang Z; Xiong J; Jiang M; Zhang Z
J Neurosci Res; 2014 Jun; 92(6):743-50. PubMed ID: 24482305
[TBL] [Abstract][Full Text] [Related]
8. Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis.
Luo B; Han F; Xu K; Wang J; Liu Z; Shen Z; Li J; Liu Y; Jiang M; Zhang ZY; Zhang Z
J Neurosci; 2016 Sep; 36(37):9590-603. PubMed ID: 27629711
[TBL] [Abstract][Full Text] [Related]
9. Chrysin attenuates experimental autoimmune neuritis by suppressing immuno-inflammatory responses.
Xiao J; Zhai H; Yao Y; Wang C; Jiang W; Zhang C; Simard AR; Zhang R; Hao J
Neuroscience; 2014 Mar; 262():156-64. PubMed ID: 24412705
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid attenuates inflammation of optic nerve and apoptosis of retinal ganglion cells in a rat model of optic neuritis.
Liu Q; Li H; Yang J; Niu X; Zhao C; Zhao L; Wang Z
Biomed Pharmacother; 2017 Dec; 96():1363-1370. PubMed ID: 29198746
[TBL] [Abstract][Full Text] [Related]
11. FTY720 controls disease severity and attenuates sciatic nerve damage in chronic experimental autoimmune neuritis.
Kremer L; Taleb O; Boehm N; Mensah-Nyagan AG; Trifilieff E; de Seze J; Brun S
J Neuroinflammation; 2019 Mar; 16(1):54. PubMed ID: 30825874
[TBL] [Abstract][Full Text] [Related]
12. Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline.
Zhang ZY; Zhang Z; Fauser U; Schluesener HJ
J Cell Mol Med; 2009 Feb; 13(2):341-51. PubMed ID: 18400050
[TBL] [Abstract][Full Text] [Related]
13. Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81.
Zhu J; Deng GM; Levi M; Wahren B; Diab A; van der Meide PH; Link H
J Neuropathol Exp Neurol; 1998 Mar; 57(3):291-301. PubMed ID: 9600221
[TBL] [Abstract][Full Text] [Related]
14. Distribution of Foxp3(+) T-regulatory cells in experimental autoimmune neuritis rats.
Zhang Z; Zhang ZY; Fauser U; Schluesener HJ
Exp Neurol; 2009 Mar; 216(1):75-82. PubMed ID: 19100737
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin-derived nonerythropoietic peptide ameliorates experimental autoimmune neuritis by inflammation suppression and tissue protection.
Liu Y; Luo B; Han F; Li X; Xiong J; Jiang M; Yang X; Wu Y; Zhang Z
PLoS One; 2014; 9(3):e90942. PubMed ID: 24603865
[TBL] [Abstract][Full Text] [Related]
16. IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses.
Bai XF; Zhu J; Zhang GX; Kaponides G; Höjeberg B; van der Meide PH; Link H
Clin Immunol Immunopathol; 1997 May; 83(2):117-26. PubMed ID: 9143372
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats.
Zou LP; Pelidou SH; Abbas N; Deretzi G; Mix E; Schaltzbeerg M; Winblad B; Zhu J
J Neuroimmunol; 1999 Aug; 98(2):168-75. PubMed ID: 10430050
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of Rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-gamma and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous system.
Abbas N; Zou LP; Pelidou SH; Winblad B; Zhu J
Autoimmunity; 2000 Sep; 32(2):93-9. PubMed ID: 11078155
[TBL] [Abstract][Full Text] [Related]
19. Suppression of experimental autoimmune neuritis by leflunomide.
Korn T; Toyka K; Hartung HP; Jung S
Brain; 2001 Sep; 124(Pt 9):1791-802. PubMed ID: 11522581
[TBL] [Abstract][Full Text] [Related]
20. Inflammation and proinflammatory cytokine production, but no demyelination of facial nerves, in experimental autoimmune neuritis in Lewis rats.
Zhu W; Mix E; Zhu J
J Neuroimmunol; 2003 Jul; 140(1-2):97-101. PubMed ID: 12864976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
